FDA Inspection
Biomat USA, Inc.Biomat USA, Inc. – FDA Inspection, Sep 22, 2011
Record Details
This FDA Inspection record concerns Biomat USA, Inc., with an inspection on September 22, 2011, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA, Inc.
- Inspection Date
- September 22, 2011
- Product Type
- Biologics
View Company Profile
ID · 09f09b8d-6067-4b2a-8081-6f2b002f7bb6
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 747581
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.100(b)(1)Donor criteria
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA, Inc.
4| Date | Classification | Office | Project area |
|---|---|---|---|
| September 6, 2019 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 16, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 12, 2013 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| April 1, 2009 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc.
- FDA Inspection 1105504 - 2019-09-06
- FDA Inspection 848169 - 2013-08-16
- FDA Inspection 832517 - 2013-04-12
- FDA Inspection 573528 - 2009-04-01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.